Next-Generation Artificial Pancreas System Launches

Medtronic’s New MiniMed®640G Artificial Pancreas System Predicts and Helps Prevent Deadly Low Glucose Emergencies A four year-old Australian boy with type 1 diabetes (T1D) is the first person to use a groundbreaking commercial artificial pancreas system that can predict and automatically prevent low blood-glucose emergencies. Medtronic’s MiniMed® 640G is an insulin pump/continuous glucose monitor combination […]

T1D Trial Looks to Teach an Old Drug New Tricks

JDRF-funded clinical study of a drug called TUDCA looks to improve beta cell functioning in people recently diagnosed with T1D Until recently, much of type 1 diabetes (T1D) research has focused on suppressing the autoimmune system to prevent or reverse disease, but this approach has been slow to yield promising, long-term results in people with […]

JDRF TypeOneNation

JDRF TypeOneNation

JDRF Heartland Chapter 2015 TypeOneNation! On Saturday, January 24, the JDRF Heartland Chapter hosted its annual TypeOneNation Outreach Event at the Embassy Suites, Omaha-La Vista. More than 200 people attended the event, with over 70 families from Omaha, Lincoln, and greater Nebraska! The event was a great opportunity to meet other individuals living with type 1 diabetes […]

Re-educating the Immune System in T1D

JDRF partner Selecta developed a novel technology for creating a T1D vaccine to potentially halt the disease process It has been more than 30 years since scientists identified the basic autoimmune feature of type 1 diabetes (T1D) when they discovered autoantibodies binding to targets from cells in the pancreas. And yet, devising therapies to halt […]

Unlocking a Combination Therapy for New Onset T1D

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

Going Digital

We Heard You! In an effort to lower costs and drive more money towards T1D research our bi-annual chapter newsletter Discoveries is going paperless. To be added to the distribution list please email Omaha@jdrf.org – subject line “JDRF E-newsletter”.

Honorariums and Memorials

Honorariums and Memorials The JDRF Heartland Chapter, Omaha-Council Bluffs is deeply grateful for the thoughtfulness of the following individuals, organizations and corporations. These contributions hasten the day when T1D and all of its life threatening complications will be eliminated. If you wish to acknowledge someone special by making a donation in his or her honor […]

2015 Ride to Cure Diabetes

2015 Ride to Cure Diabetes

Ready, Set, Ride! Join us for the 2015 Ride to Cure Diabetes – be part of the team that moves us towards a cure with every mile pedaled and every dollar raised. The Ride is an experience like no other – a destination cycling event that takes place in several stunning locations across the United […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]